News & Updates

In the treatment of patients with hypercholesterolaemia, the fixed-dose combination of pitavastatin plus ezetimibe, 1PC111, affords better low-density lipoprotein cholesterol (LDL-C)-lowering effect than either pitavastatin or ezetimibe alone, according to the results of a phase III trial.

Dual therapy with the fixed-dose combination of darunavir/ritonavir plus lamivudine effectively controlled HIV as the same combination with tenofovir in treatment-naïve patients with HIV, according to the phase IV ANDES trial presented at AIDS 2022.

The risk of developing infection following operative vaginal birth is high when episiotomy is performed, forceps are used, and among women who are primiparous and overweight, a study has found. As such, timely prophylactic antibiotics should be given.

When administered concomitantly with oxytocin, prophylactic granisetron appears to have no negative impact on myometrial contraction during caesarean delivery, reports a recent study.

The combination of nivolumab 1 mg/kg (NIVO1) and ipilimumab 3 mg/kg (IPI3) every 3 weeks followed by NIVO 240 mg every 2 weeks in the second-line setting continues to confer durable response and overall survival (OS) benefit in patients with advanced hepatocellular carcinoma (aHCC), according to 5-year data from the CheckMate 040* trial presented at ESMO GI 2022.

Treatment with revacept 120 mg appears to be beneficial in the treatment of patients with symptomatic internal carotid artery stenosis, according to a study.